(HealthDay)—Use of pembrolizumab is supported among patients with advanced melanoma, regardless of BRAF V600E/K mutation status or prior receipt of
Continue reading »
Home »
Triple-drug therapy TRIPLES survival rate of advanced breast cancer
Patients with terminal breast cancer could live for up to FIVE MONTHS longer by taking a cocktail of three drugs,
Continue reading »
Telerehabilitation aids function, pain with advanced cancer
(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in
Continue reading »
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
BOTHELL, Wash. and TOKYO, March 28, 2019 /PRNewswire/ — Seattle Genetics, Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE: 4503,
Continue reading »
High-dose vitamin D shows benefit in patients with advanced colorectal cancer
Results of a small clinical trial suggest that supplementing chemotherapy with high doses of vitamin D may benefit patients with
Continue reading »
SNMMI image of the year: PSMA PET imaging of theranostic for advanced prostate cancer
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to radionuclide therapy targeting prostate
Continue reading »
Financial decision-making capacity need not decline in healthy advanced aging
New research from The Center for BrainHealth at The University of Texas at Dallas shows that advancing age alone is
Continue reading »
Cancer drug keytruda a new weapon against advanced lung tumors
(HealthDay)—A cancer drug that boosts the immune system outperforms chemotherapy in fighting advanced lung cancer, a new trial shows. Keytruda
Continue reading »
Zika virus eliminates advanced human tumor in central nervous system of rodents
A Brazilian study published April 26 in the journal Cancer Research shows for the first time in vivo that Zika
Continue reading »